Class Action Against Bayer, Manufacturer of Trasylol
There are estimates that at least 10,000 patients may unnecessarily have suffered kidney damage due to use of aprotinin (Trasylol) during heart surgery. Many patients may have been injected with Trasylol to reduce blood loss during coronary artery bypass (CABG) surgery. Thus, the goal with using Trasylol was to stop bleeding during the heart bypass [...]
